Technojet Consultants Clears Capital Expansion and Preferential Issue

The 1st EGM of FY 2026-2027 saw 100% of votes cast in favor of all proposed resolutions.
Technojet Consultants will issue 5,00,000 equity shares at a price of Rs 48 per share to non-promoters.

Reader Takeaway: Shareholders unanimously backed the capital raise, providing Technojet with new liquidity while diluting current equity stakes.

What just happened

Technojet Consultants Ltd held its 1st Extraordinary General Meeting (EGM) for the financial year 2026-2027 on October 30, 2026. Shareholders approved two special resolutions with a unanimous 100% vote. The participating shareholders represented 83.14% of the company's paid-up capital, totaling 1,66,286 shares.

Why this matters

The approved resolutions allow the company to expand its authorised share capital and execute a preferential issue of equity shares. By issuing 5,00,000 shares at Rs 10 face value with a premium, priced at Rs 48 per share, the company is set to raise significant capital from non-promoter investors. This move suggests an active push for funding to potentially support business expansion or debt reduction.

What changes now

Following this approval, the company will initiate the allotment process for the 5,00,000 equity shares. Investors should watch for further filings regarding the list of allottees and the specific timeline for credit of these shares into the beneficiaries' demat accounts. The modification of the Memorandum and Articles of Association will also be formalized to reflect the new authorised capital structure.

Risks to watch

While the resolution passed unanimously, existing shareholders should remain mindful of the dilution impact on their earnings per share following the issuance of 5 lakh new shares. The effective utilization of these proceeds remains the key factor in long-term value creation.

What to track next

Watch for disclosures regarding the identity of the non-promoter investors participating in the preferential issue. Additionally, monitor subsequent quarterly results to assess how the infusion of fresh capital contributes to the company's operational growth and bottom-line performance.